Abbott Laboratories (ABT)
(Real Time Quote from BATS)
$103.55 USD
-0.83 (-0.80%)
Updated Jun 13, 2024 03:26 PM ET
3-Hold of 5 3
C Value C Growth C Momentum C VGM
Brokerage Reports
0 items in cart
Abbott Laboratories [ABT]
Reports for Purchase
Showing records 441 - 460 ( 528 total )
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Second Quarter Revenue Higher Despite Significant Currency Headwinds
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Pro-forma Overview of Pure Play Pharmaceutical Spinoff
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Separation of businesses to result in unlocking of their true value...
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Higher Sales and Margin Improvement Drive Low Teens First Quarter EPS Growth
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Specialty Pharmaceuticals Short Interest Analysis
Provider: AURIGA USA
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
Sales Held Back by Less Favorable Currency Trends and Slowing Vascular Revenue
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
With RAC Prepayment Audit Pressures Systemic, We Continue to Prefer STJ On Steady Share Gains & SYK Given Diversified Footprint
Provider: KAUFMAN BROTHERS
Analyst: CERVANTES V
Company: Abbott Laboratories
Industry: Large Cap Pharmaceuticals
In Today''s Morning Exchange
Provider: KAUFMAN BROTHERS